JoVE Logo
Faculty Resource Center

Sign In

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

DOI :

10.3791/63028-v

12:53 min

March 16th, 2022

March 16th, 2022

1,360 Views

1Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, 2Department of Pathology and Laboratory Medicine, University of California, 3School of Medicine, Radiation Oncology, University of California Davis

This protocol describes using commercial, cell-free protein expression kits to produce membrane proteins supported in nanodisc that can be used as antigens in subunit vaccines.

Tags

Cell Free

-- Views

Related Videos

article

Recombinant Retroviral Production and Infection of B Cells

article

Production and Titering of Recombinant Adeno-associated Viral Vectors

article

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

article

Forward Genetic Approaches in Chlamydia trachomatis

article

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

article

Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis

article

In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection

article

Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages

article

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques

article

Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved